ID   St-4/cDDP
AC   CVCL_Y176
SY   St/DDP
DR   CGH-DB; 9109-4
DR   Wikidata; Q54955734
RX   PubMed=9816187;
RX   PubMed=14973057;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H265 ! St-4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
RX   PubMed=9816187;
RA   Yamada M., Tomida A., Yoshikawa H., Taketani Y., Tsuruo T.;
RT   "Increased expression of thioredoxin/adult T-cell leukemia-derived
RT   factor in cisplatin-resistant human cancer cell lines.";
RL   Clin. Cancer Res. 2:427-432(1996).
//
RX   PubMed=14973057; DOI=10.1158/0008-5472.CAN-3263-2;
RA   Yasui K., Mihara S., Zhao C., Okamoto H., Saito-Ohara F., Tomida A.,
RA   Funato T., Yokomizo A., Naito S., Imoto I., Tsuruo T., Inazawa J.;
RT   "Alteration in copy numbers of genes as a mechanism for acquired drug
RT   resistance.";
RL   Cancer Res. 64:1403-1410(2004).
//